Home » Topics » BioWorld Science

BioWorld Science
RSS

New EGFR mutant inhibitors identified at Betta Pharmaceuticals

Sep. 9, 2021

Amgen describes new PRMT5 inhibitors

Sep. 9, 2021

New IRAK-4/FLT-3 inhibitors identified at PharmaBlock Sciences

Sep. 9, 2021

Genfleet Therapeutics discovers RIP-1 inhibitors

Sep. 9, 2021

GABA-A alpha5 PAM RO-7015738 presented for neurological disorders

Sep. 9, 2021

New sporadic Alzheimer's disease animal model may improve drug testing

Sep. 9, 2021

New MAP4K4 inhibitors identified for suppressing cardiac muscle cell death

Sep. 9, 2021

Synthesis and optimization of LRRK2 inhibitors using a CHK1-derived crystallographic surrogate

Sep. 9, 2021

AAV integration frequencies "surprisingly high," study finds

Sep. 8, 2021

[44Sc]Sc-B28110 shows preclinical promise as a radiotracer for the imaging of prostate cancer

Sep. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...